Literature DB >> 27184467

Area of Skin Numbness After Total Knee Arthroplasty: Does Minimally Invasive Approach Make Any Difference From Standard Approach?

Aree Tanavalee1, Arak Limtrakul2, Pathomporn Veerasethsiri3, Chavarin Amarase1, Srihatach Ngarmukos1.   

Abstract

BACKGROUND: Skin numbness after total knee arthroplasty (TKA) was reported in relation to injury of the infrapatellar branch of saphenous nerve (IPBSN).
METHODS: Phase I study: A nonrandomized and nonconsecutive selection of 30 patients undergoing unilateral TKA, using minimally invasive surgery approach, and 30 patients having standard approach were included. Area of skin numbness was periodically evaluated and compared until 1-year follow-up (FU). Phase II study: we dissected 15 normal cadaveric knees and followed the course and distribution of IPBSN.
RESULTS: Twenty-nine predominantly female patients in each group completed 1-year FU with no differences in demographic data. Both the groups had significantly improved Knee Society Score clinical and function scores with no statistical differences. The numb areas in both the groups similarly decreased from 2 weeks (51.7 cm2 vs 51.1 cm2) to 1 year (2.1 cm2 vs 2.4 cm2) with similar percentages of no skin numbness at 1 year (69% vs 65%). The IPBSN branched from saphenous nerve before exiting the adductor canal and ran longitudinally and obliquely. It was found as a single nerve in 20%, a 2-branch nerve in 67% and a 3-branch nerve in 13%. All branches crossed the knee midline between superior patellar pole and tibial tubercle.
CONCLUSION: Clinical study showed that TKA using minimally invasive surgery approach provided similar area of skin numbness to standard approach. Numbness area gradually decreased at serial FUs in both the groups. The cadaveric study demonstrated that the IPBSN consistently gave no branch passing the knee midline above superior patellar pole.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MIS approach; TKA; minimally invasive surgery; skin numbness; total knee arthroplasty

Mesh:

Year:  2016        PMID: 27184467     DOI: 10.1016/j.arth.2016.04.002

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  Cadaveric study of the infrapatellar branch of the saphenous nerve: Can damage be prevented in total knee arthroplasty?

Authors:  Sung R Lee; Nicholas J P Dahlgren; Jackson R Staggers; Cesar de Cesar Netto; Amit Agarwal; Ashish Shah; Sameer Naranje
Journal:  J Clin Orthop Trauma       Date:  2018-03-09

2.  Anterior skin numbness after total knee arthroplasty: A prospective comparison study between diabetic and non-diabetic patients.

Authors:  Ong-Art Phruetthiphat; Rit Apinyankul; Malee Chanpoo; Thanainit Chotanaphuti; Weerachai Kosuwan; John J Callaghan
Journal:  J Orthop       Date:  2020-03-25

3.  A prospective randomized study in 20 patients undergoing bilateral TKA comparing midline incision to anterolateral incision.

Authors:  Rajesh N Maniar; Tushar Singhi; Arun Nanivadekar; Parul R Maniar; Jaivardhan Singh
Journal:  J Orthop Traumatol       Date:  2017-02-11

4.  Correlation of patient-reported numbness around surgical scars with patient-reported outcome measures and joint awareness after knee replacement: a cohort study.

Authors:  Masafumi Itoh; Junya Itou; Umito Kuwashima; Ken Okazaki
Journal:  BMC Musculoskelet Disord       Date:  2022-01-03       Impact factor: 2.362

5.  No Effect of Oral Mecobalamin on Skin Numbness at 3 Months After Total Knee Arthroplasty: A Randomized, Double-Blinded, Placebo-Controlled Superiority Trial.

Authors:  Pakpoom Ruangsomboon; Sarthak Nepal; Pacharapol Udomkiat; Aasis Unnanuntana
Journal:  JB JS Open Access       Date:  2022-04-08

6.  Cutaneous nerve fields of the anteromedial lower limb-Determination with selective ultrasound-guided nerve blockade.

Authors:  Georg Riegler; Christopher Pivec; Suren Jengojan; Johannes A Mayer; Christoph Schellen; Siegfried Trattnig; Gerd Bodner
Journal:  Clin Anat       Date:  2020-02-29       Impact factor: 2.414

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.